Investigational Therapies for Schizotypal Personality Disorder

Pharmacological and Psychotherapeutic Interventions

Various other pharmacological agents, including glutamatergic agents, antidepressants, stimulants, anticholinesterase agents, vitamins/nutraceuticals, anti-inflammatory drugs, and hormones, are being investigated for negative symptoms in schizophrenia spectrum disorders, which may eventually be applicable to schizotypal personality disorder 1, 2, 3, 4
Cognitive-behavioral therapy, cognitive remediation therapy, mindfulness-based therapy, and supportive psychoeducation are being investigated for schizophrenia spectrum disorders, with potential applicability to schizotypal personality disorder 3

Repetitive Transcranial Magnetic Stimulation (rTMS), Transcranial Direct Current Stimulation (tDCS), and Electroconvulsive Therapy (ECT) are being investigated for schizophrenia spectrum disorders, with potential applicability to schizotypal personality disorder 1, 2, 3

Treatment should follow ethical guidelines established for psychiatric disorders, including appropriate oversight by ethics committees or institutional review boards 5, 6
Comprehensive preoperative evaluation and patient selection criteria are essential for any investigational neurosurgical approaches 6
For experimental treatments, it's critical to distinguish between established therapeutic interventions and those that remain investigational 6